bloodstream
infect
bsi
sepsi
rise
incid
throughout
develop
world
spread
multidrug
resist
organ
present
increas
challeng
treatment
surviv
bsi
depend
rapid
accur
identif
causal
organ
time
applic
appropri
antibiot
current
culturebas
method
use
detect
identifi
agent
bsi
often
slow
impact
earli
therapi
may
fail
detect
relev
organ
mani
posit
case
exist
method
direct
molecular
detect
microbi
dna
blood
limit
either
sensit
like
result
small
sampl
volum
breadth
coverag
often
pcr
primer
probe
use
target
specif
pathogen
clear
unmet
need
sensit
molecular
assay
capabl
identifi
divers
bacteria
yeast
associ
bsi
directli
uncultur
whole
blood
sampl
develop
method
extract
dna
larger
volum
whole
blood
ml
per
sampl
amplifi
multipl
wide
conserv
bacteri
fungal
gene
use
mismatchand
backgroundtoler
pcr
chemistri
identifi
hundr
divers
organ
amplifi
fragment
basi
speciesspecif
genet
signatur
use
electrospray
ioniz
mass
spectrometri
pcresim
describ
analyt
characterist
iridica
bac
bsi
assay
compar
preclin
perform
current
standardofcar
method
collect
prospect
collect
blood
specimen
patient
symptom
sepsi
assay
gener
match
result
cultureposit
case
common
contamin
exclud
analysi
twice
total
number
posit
detect
describ
method
capabl
provid
organ
identif
directli
uncultur
blood
less
hour
disclaim
iridica
bac
bsi
assay
avail
unit
state
bloodstream
infect
bsi
associ
clinic
sepsi
repres
major
sourc
mortal
develop
world
rank
rd
lead
caus
death
germani
th
unit
state
increas
number
elderli
immunocompromis
patient
well
increas
use
implant
medic
devic
incid
sepsi
rise
rapidlybi
franc
mortal
rate
rang
high
situat
constitut
public
health
disast
averag
total
cost
associ
individu
case
germani
unit
state
estim
respect
annual
nation
burden
billion
billion
primari
factor
affect
clinic
outcom
financi
burden
bsi
prompt
treatment
appropri
antibiot
mortal
risk
doubl
hour
delay
provis
appropri
antibiot
case
bacteremia
hour
delay
provis
antifung
case
candidemia
current
culturebas
method
use
detect
identifi
agent
bloodstream
infect
inadequ
incub
time
day
may
necessari
captur
major
cultur
bacteria
fungi
associ
bsi
though
mani
infect
detect
hour
time
requir
obtain
identif
via
maldi
tof
dna
sequenc
tradit
biochem
analysi
tempor
delay
leav
practition
littl
choic
treat
patient
suspect
bsi
empir
use
broadspectrum
antibiot
strategi
result
septic
patient
receiv
inappropri
antibiot
therapi
turn
associ
higher
mortal
risk
risk
deriv
empir
use
antibiot
ineffect
rarer
organ
vancomycinresist
enterococci
vre
candida
standard
culturebas
method
hamper
treatment
inhibitori
antibiot
prior
sampl
insensit
noncultiv
fastidi
organ
coxiella
burnetii
tropheryma
whipplei
speci
genera
bartonella
rickettsia
mycobacterium
nocardia
mani
organ
identifi
causal
agent
bsi
cultureindepend
molecular
method
singleanalyt
pcr
ribosom
gene
sequenc
howev
method
lack
either
coverag
necessari
identifi
divers
agent
bsi
sensit
consist
detect
agent
directli
blood
major
case
despit
low
appar
sensit
exist
broadspectrum
molecular
method
respect
cultureapproxim
mani
technolog
method
frequent
yield
addit
posit
result
cultureneg
blood
sampl
posit
molecular
detect
often
confirm
later
cultur
perform
sampl
taken
patient
strongli
correl
sepsisassoci
biomark
shown
improv
patient
outcom
use
guid
antibiot
therapi
molecular
detect
bacteria
cultureneg
specimen
correl
antibiot
pretreat
primarili
identifi
speci
known
causal
agent
bsi
correl
suggest
mani
cultureneg
pcrposit
detect
repres
cultur
insensit
rather
lack
specif
clinic
relev
part
molecular
method
support
literatur
wide
report
blood
cultur
posit
case
bsi
strongli
suspect
clinic
standpoint
clear
unmet
need
rapid
sensit
molecular
detect
identif
bsi
agent
directli
blood
sampl
meet
need
develop
univers
lysi
dna
extract
method
capabl
sampl
ml
whole
blood
pair
conservedsit
pcr
primer
capabl
gener
amplicon
eubacteria
candida
speci
associ
human
infect
pcr
chemistri
cycl
condit
compat
high
concentr
background
human
dna
method
util
autom
desalt
dna
debulk
platform
prepar
amplicon
mass
spectrometri
electrospray
ioniz
mass
spectrometri
esim
platform
capabl
discrimin
amplicon
sequenc
variant
one
differ
speci
present
sampl
onboard
analysi
comput
use
pars
report
detect
speci
bacteria
candida
basi
multilocu
amplicon
base
composit
signatur
qualiti
control
includ
extern
lysi
control
intern
pcr
control
extern
mass
spectrometri
standard
signal
strength
qualiti
metric
studi
explor
analyt
sensit
specif
robust
reproduc
breadth
coverag
iridica
bac
bsi
assay
perform
iridica
system
compar
perform
tradit
culturebas
method
collect
prospect
collect
clinic
whole
blood
specimen
cultur
quantif
microbi
stock
microbi
stock
obtain
atcc
manassa
va
clinic
laboratori
grown
appropri
media
quantifi
standard
dilut
colonycount
method
ibi
bioscienc
carlsbad
california
zeptometrix
buffalo
new
york
stock
store
frozen
glycerol
thaw
dilut
test
matric
store
test
immedi
clinic
sampl
collect
test
two
hundr
eightyf
ml
whole
blood
sampl
prospect
collect
consent
patient
present
john
hopkin
hospit
emerg
depart
met
least
two
sir
criteria
sepsi
sampl
collect
phlebotomist
edta
blood
tube
follow
blood
draw
taken
standardofcar
cultur
analysi
use
venipunctur
sampl
blind
replac
identifi
inform
numer
identifi
studi
coordin
frozen
transport
ibi
bioscienc
dri
ice
chart
data
standardofcar
cultur
result
collect
thereaft
john
hopkin
hospit
studi
coordin
associ
respect
blind
sampl
ident
also
blind
respect
patient
ident
ibi
bioscienc
perform
iridica
bac
bsi
assay
test
absenc
chart
cultur
data
pair
specimen
taken
clinic
test
process
per
standard
care
clinic
microbiolog
laboratori
john
hopkin
hospit
knowledg
iridica
bac
bsi
assay
result
result
report
clinic
microbiolog
laboratori
use
compar
two
independ
gener
dataset
iridica
cultur
brought
togeth
comparison
method
perform
data
traceabl
document
clinic
laboratori
cultur
identif
clinic
microbiolog
laboratori
use
bactec
fx
bd
diagnost
spark
md
continu
monitor
blood
cultur
instrument
bottl
routin
use
clinic
care
includ
bactec
anaerob
bottl
bactec
plu
aerobicf
bottl
contain
resin
antibiot
neutral
use
patient
antibiot
time
blood
draw
bactec
aerob
bottl
allpurpos
medium
contain
resin
recommend
patient
antibiot
time
blood
draw
laboratori
blood
cultur
procur
polici
recommend
clinician
send
minimum
two
set
blood
cultur
set
consist
aerob
bottl
either
standard
aerob
plu
anaerob
lytic
bottl
inocul
ml
blood
aerob
gramposit
cocci
gramneg
rod
routin
identifi
use
phoenix
system
bd
diagnost
inc
spark
md
anaerob
identifi
follow
recoveri
routin
media
use
either
malditof
mass
spectrometri
bruker
billerica
rapid
ana
ii
system
thermoscientif
waltham
gramposit
rod
identifi
use
either
phoenix
system
malditof
ms
cell
wall
fatti
acid
analysi
use
ga
liquid
chromatographi
depend
upon
genera
isol
candida
speci
identifi
use
recoveri
chromagar
morpholog
phoenix
system
yeast
panel
phenotyp
resistancetyp
method
perform
isol
use
phoenix
system
associ
gramneg
gramposit
panel
bd
diagnost
spark
md
extendedspectrum
betalactamas
etest
biomerieux
durham
nc
modifi
hodg
test
molecular
test
meca
vana
vanb
perform
use
verigen
bcid
microarray
system
nanospher
northbrook
il
iridica
system
pcresim
test
perform
use
iridica
system
compon
associ
reagent
abbott
molecular
de
plain
il
includ
highvolum
beadbeat
platform
iridica
bb
autom
dna
extract
pcr
setup
platform
iridica
sp
pcr
thermocycl
iridica
tc
autom
amplicon
desalt
dna
debulk
platform
iridica
ds
autom
electrospray
ioniz
mass
spectromet
iridica
ms
control
analysi
comput
iridica
ac
function
compon
previous
describ
system
capabl
run
sampl
simultan
batch
subsequ
batch
may
start
hour
follow
initi
first
test
describ
perform
run
multipl
overlap
batch
test
day
instrument
sampl
requir
approxim
minut
handson
time
singl
technician
run
batch
mode
hour
handson
time
batch
sampl
involv
reagent
prepar
sampl
load
transfer
instrument
instrument
decontamin
handson
requir
interspers
tempor
throughout
first
hour
process
requir
train
laboratori
technician
compet
steril
techniqu
meter
fluid
transfer
vortex
pipet
use
clinic
centrifug
bar
code
scan
track
sampl
equip
user
reagent
result
time
first
result
averag
approxim
hour
iridica
bac
bsi
assay
test
util
iridica
bac
bsi
assay
kit
includ
prefil
pcr
reaction
strip
encompass
primer
pair
well
primer
target
broadli
conserv
bacteri
candida
gene
specif
antibiot
resist
marker
meca
vana
vanb
bla
kpc
extract
control
target
reaction
cycl
condit
optim
function
sampl
high
human
dna
background
describ
previous
mass
spectrometri
signal
unfrag
amplicon
process
use
analysi
softwar
databas
element
design
translat
raw
spectral
data
base
composit
signatur
detect
amplicon
softwar
perform
signatur
match
detect
base
composit
multilocu
speciesspecif
signatur
deriv
analysi
type
strain
survey
wholegenom
data
genbank
core
test
organ
iridica
bac
bsi
assay
detect
identifi
target
bacteria
use
common
set
primer
analysi
algorithm
true
target
candida
basi
unifi
function
tier
approach
valid
follow
four
core
organ
togeth
util
primer
pair
assay
use
analyt
studi
design
challeng
assay
abil
detect
target
organ
concentr
near
limit
detect
lod
variou
circumst
core
organ
includ
meca
staphylococcu
aureu
mrsa
vanavanb
enterococcu
faecium
vre
bla
kpc
klebsiella
pneumonia
kpc
candida
albican
analyt
studi
limit
detect
lod
assay
character
core
organ
ml
aliquot
edta
whole
blood
steril
buffer
iridica
neg
control
abbott
molecular
de
plain
il
base
result
demonstr
compar
sensit
matric
lod
addit
bacteria
candida
speci
determin
confirm
steril
buffer
lod
measur
initi
test
replic
sever
dilut
step
determin
lod
defin
lowest
concentr
replic
detect
correctli
identifi
includ
organ
known
drug
resist
marker
follow
confirm
test
use
replic
determin
lod
final
report
lod
defin
lowest
concentr
least
replic
detect
correctli
identifi
anoth
speci
test
singl
concentr
steril
buffer
confirm
design
breadth
coverag
assay
robust
challeng
studi
potenti
interf
substanc
edta
whole
blood
potenti
crossreact
organ
carryov
steril
buffer
inhous
reproduc
analysi
use
multipl
instrument
reagent
lot
user
edta
whole
blood
alongsid
sampl
prepar
steril
buffer
bodi
fluid
tissu
carryov
crossreact
studi
perform
high
titer
studi
perform
use
core
organ
lod
clinic
sampl
perform
evalu
compar
iridica
bac
bsi
assay
result
cultur
result
use
prospect
collect
edta
whole
blood
specimen
consent
subject
suspect
bsi
assay
control
analyt
clinic
sampl
test
carri
control
scheme
use
integr
autom
posit
control
control
includ
extract
control
target
ad
sampl
intern
pcr
calibr
formul
reaction
well
pcr
calibr
synthet
competit
dna
construct
contain
assay
primer
bind
site
one
assay
primer
pair
contain
well
construct
design
produc
uniqu
base
composit
signatur
readili
discrimin
expect
amplicon
produc
target
analyt
calibr
includ
pcr
well
defin
concentr
use
compet
low
level
background
templat
gaug
templat
input
level
neg
control
consist
steril
buffer
run
part
everi
set
sampl
run
concurr
platform
posit
detect
neg
control
associ
test
result
yield
detect
exclud
rate
test
valid
cours
experi
describ
analyt
spike
sampl
studi
neg
result
pair
valid
secondari
detect
unspik
organ
contamin
exclud
basi
potenti
competit
interfer
part
standard
care
collect
facil
gener
drew
test
two
independ
blood
sampl
inocul
blood
cultur
bottl
set
consist
one
aerob
one
anaerob
bottl
perform
multipl
cultur
common
practic
increas
sensit
discrimin
contamin
event
clinic
relev
detect
contamin
gener
character
singl
unrep
detect
common
contamin
coagulaseneg
staphylococci
viridan
group
streptococci
speci
corynebacterium
bacillu
micrococcu
propionibacterium
genera
bsi
gener
character
singl
repeat
detect
organ
strongli
associ
bsi
mrsa
kpc
vre
repeat
detect
potenti
contamin
organ
studi
cultur
result
singl
blood
cultur
bottl
set
compar
iridica
bac
bsi
assay
result
singl
test
sampl
one
sampl
collect
subject
test
iridica
system
case
test
sampl
obtain
venipunctur
sampl
use
inocul
specif
blood
bottl
set
pair
clearli
document
associ
cultur
result
use
compar
case
specif
link
test
sampl
clinic
sampl
could
confirm
approxim
one
third
case
first
report
cultur
result
day
use
compar
avail
result
secondari
cultur
bottl
set
speciesspecif
pathogen
identif
result
patient
chart
data
use
assess
iridica
bac
bsi
assayposit
cultureneg
discrep
discuss
singl
posit
detect
common
contamin
organ
question
clinic
relev
specif
cultur
organ
known
low
therefor
comparison
cultur
iridica
bac
bsi
assay
made
without
consider
common
contamin
organ
cultur
iridica
bac
bsi
assay
report
presenc
bacteri
speci
associ
one
drug
resist
marker
target
iridica
bac
bsi
assay
iridica
bac
bsi
assay
resist
marker
result
compar
phenotyp
genotyp
resist
data
report
clinic
laboratori
part
postcultur
standardofcar
isol
character
case
either
iridica
bac
bsi
assay
cultur
neg
bacteria
resist
comparison
could
made
method
report
resist
marker
phenotyp
associ
specif
bacteri
detect
limit
detect
measur
four
core
organ
edta
whole
blood
steril
buffer
matric
see
fig
four
core
organ
lod
within
two
matric
analyt
studi
perform
steril
buffer
except
note
confirm
limit
detect
iridica
bac
bsi
assay
addit
bacteria
candida
repres
breadth
coverag
assay
shown
fig
geometr
mean
log
lod
speci
cfuml
rang
cfu
ml
gener
limit
detect
support
theoret
abil
assay
detect
bacteria
directli
blood
bsi
patient
literatur
suggest
bsi
patient
carri
approxim
pcrdetect
genom
copi
infect
organ
per
ml
blood
contrast
low
level
cultur
bacteria
cfuml
grown
directli
blood
patient
speci
assay
lod
cfuml
streptococci
occur
chain
therefor
high
variabl
genom
cfu
ratio
assay
success
detect
addit
divers
bacteria
candida
speci
replic
test
singl
concentr
organ
shown
fig
includ
speci
isol
cultur
bsi
case
organ
repres
full
phylogenet
breadth
assay
five
organ
identifi
bioinformat
worstcas
organ
assay
primer
poorli
match
crossreact
character
sampl
contain
cfuml
copiesml
tcid
ml
varieti
fungi
bacteria
virus
assay
design
report
includ
aspergillu
flavu
aspergillu
niger
clavispora
lusitania
candida
kefyr
caulobact
segni
pedobact
heparinu
shewanella
oneidensi
streptomyc
griseu
influenza
parainfluenza
adenoviru
parvoviru
coronaviru
herpesviru
crossreact
observ
assay
abl
detect
identifi
lod
spike
four
core
organ
edta
whole
blood
supplement
potenti
interf
substanc
list
tabl
one
substanc
test
concentr
correspond
recommend
clsi
organ
test
analyt
studi
four
core
organ
shown
bold
lod
blood
buffer
shown
parenthes
blood
lod
cfu
per
ml
buffer
lod
cfu
per
ml
lod
organ
buffer
also
shown
parenthes
remain
organ
shown
blue
purpl
test
detect
replic
either
cfuml
except
bacteroid
fragili
cfuml
bacteroid
fragili
indic
bioinformat
worstcas
scenario
organ
broadspectrum
primer
use
iridica
bac
bsi
assay
least
wellmatch
standard
guidanc
except
bilirubin
test
prepar
heavili
contamin
bacteri
fungal
dna
despit
contamin
prevent
detect
one
spike
analyt
one
replic
competit
interfer
origin
concentr
assay
still
detect
spike
test
organ
spike
analyt
detect
bilirubin
contamin
detect
concentr
indic
extract
pcr
fulli
function
directli
affect
bilirubin
carryov
test
perform
test
adjac
neg
high
posit
sampl
posit
spike
cfusampl
either
kpc
vre
mrsa
candida
albican
test
configur
provid
independ
opportun
observ
carryov
event
adjac
high
titer
neg
sampl
carryov
event
observ
perform
sampl
contain
multipl
analyt
character
test
possibl
mixtur
two
four
core
organ
ratio
lod
triplic
iridica
bac
bsi
assay
use
share
primer
detect
relat
target
competit
interfer
may
prevent
simultan
detect
multipl
target
reason
studi
intend
demonstr
analyt
could
simultan
detect
identifi
mixtur
rather
presenc
multipl
organ
prevent
iridica
bac
bsi
assay
detect
correctli
identifi
least
one
compon
mixtur
assay
success
detect
accur
identifi
least
one
two
spike
analyt
instanc
abl
detect
identifi
spike
analyt
instanc
three
case
one
two
spike
analyt
detect
mixtur
mrsa
vrein
two
mrsa
detect
one
case
vre
detect
withinlaboratori
reproduc
iridica
bac
bsi
assay
beadbeat
sampl
prep
pcr
compon
bb
sp
tc
assay
strip
relat
reagent
character
tabl
antibiot
resist
markerphenotyp
result
shown
tabl
cultur
iridica
bac
bsi
assay
util
singl
reagent
detect
mani
target
therefor
presenc
detect
organ
mask
detect
organ
competit
interfer
cultur
faster
grow
organ
readili
outcompet
slowergrow
organ
cultur
bottl
obviat
isol
slowergrow
organ
broadspectrum
pcrbase
system
like
iridica
use
conservedsit
primer
pair
amplifi
partial
conserv
region
multipl
speci
target
better
match
specif
primer
pair
may
outcompet
speci
amplif
obscur
meaning
interpret
neg
result
sampl
alreadi
posit
least
one
analyt
analysi
present
result
cultur
iridica
bac
bsi
assay
consid
neg
sampl
yield
neg
result
analyt
posit
sampl
consid
posit
report
analyt
indetermin
other
posit
detect
therebi
indetermin
compar
assign
addit
detect
categori
final
comparison
see
tabl
two
hundr
seven
sampl
yield
match
neg
result
analyt
iridica
bac
bsi
assay
cultur
method
iridica
bac
bsi
assay
match
compar
detect
report
cultur
posit
agreement
detect
addit
organ
cultureneg
sampl
potenti
contamin
organ
list
bottom
tabl
exclud
analysi
iridica
bac
bsi
assay
result
match
compar
detect
report
cultur
posit
agreement
detect
addit
organ
identifi
cultur
major
iridica
bac
bsi
assayposit
cultureneg
detect
identifi
either
speci
commonli
associ
bsi
includ
escherichia
coli
enterococcu
faecium
klebsiella
pneumonia
staphylococcu
aureu
clinic
relev
speci
unlik
detect
common
cultur
bottl
method
includ
ehrlichia
chaffeensi
mycoplasma
homini
other
fastidi
speci
occur
pathogen
common
environment
contamin
mycobacterium
simia
eleven
iridica
bac
bsi
assayposit
cultureneg
detect
support
chart
data
show
posit
detect
organ
identifi
causal
pathogen
subsequ
standardofcar
analys
blood
biopsi
respiratori
specimen
patient
note
tabl
overal
result
obtain
clinic
sampl
studi
consist
obtain
similar
studi
compar
perform
iridica
bac
bsi
assay
cultur
separ
popul
patient
suspect
sepsi
eight
propionibacterium
acn
detect
made
iridica
bac
bsi
assay
one
cultur
none
match
assum
repres
contamin
introduc
venipunctur
sampl
prepar
reagent
handl
iridica
bac
bsi
assay
may
sensit
p
acn
contamin
cultur
method
organ
list
potenti
contamin
tabl
along
common
blood
cultur
contamin
notat
potenti
contamin
iridica
bac
bsi
assay
report
recommend
detect
wellrecogn
common
contamin
organ
blood
sampl
whether
cultur
molecular
mean
confirm
secondari
sampl
rather
assum
clinic
relev
clinic
sampl
studi
perform
follow
steril
person
protect
equip
recommend
manufactur
neg
control
test
yield
report
organ
exclud
potenti
contamin
n
cultureneg
iridica
bac
bsi
assayposit
detect
support
later
organismspecif
id
data
identifi
speci
agent
infect
note
subject
chart
number
parenthes
indic
mani
case
support
tabl
data
support
abil
iridica
bac
bsi
assay
identifi
divers
bacteria
candida
speci
directli
uncultur
edta
whole
blood
specimen
detect
clinic
relev
organ
isol
use
tradit
blood
cultur
assay
iridica
bac
bsi
assay
capabl
provid
identif
within
eight
hour
sampl
collect
potenti
allow
time
provis
appropri
target
antibiot
therapi
case
suspect
bloodstream
infect
sepsi
iridica
bac
bsi
assay
determin
antibiot
resist
phenotyp
limit
term
detect
resistanceassoci
genotyp
four
common
broadspectrum
antibiot
resist
elementsmeca
vana
vanb
kpc
inclus
determin
resist
remain
depend
success
cultur
subsequ
phenotyp
resist
type
infect
organ
reason
iridica
bac
bsi
assay
consid
addit
tool
diagnost
regim
replac
culturebas
method
similar
culturebas
method
iridica
bac
bsi
assay
sensit
infect
pathogen
environment
microorgan
introduc
sampl
collect
prepar
necessit
rigor
phlebotomi
techniqu
steril
laboratori
handl
use
neg
control
iridica
bac
bsi
assay
result
interpret
context
associ
symptom
risk
factor
laboratori
find
manner
current
standardofcar
cultur
identif
util
iridica
bac
bsi
assay
yield
approxim
twice
mani
posit
detect
cultur
across
describ
set
clinic
blood
specimen
patient
symptom
sepsi
major
case
iridica
bac
bsi
assayposit
cultureneg
detect
either
speci
commonli
associ
bsi
clinic
relev
human
pathogen
would
difficult
grow
blood
cultur
bottl
eg
ehrlichia
chaffeensi
common
contamin
eg
propionibacterium
acn
also
observ
cultureneg
specimen
despit
access
partial
chart
data
unmatch
iridica
bac
bsi
assay
detect
specif
support
subsequ
identif
andor
diagnost
data
independ
specimen
show
infect
patient
speci
initi
detect
iridica
bac
bsi
assay
mani
iridica
bac
bsi
assayposit
cultureneg
detect
therebi
repres
clinic
relev
bloodstream
infect
miss
cultur
origin
pair
specimen
consist
literatur
suggest
sensit
cultur
suboptim
broadspectrum
natur
iridica
bac
bsi
assay
primer
pair
signal
analysi
method
capabl
sensit
specif
detect
identif
one
speci
signatur
sampl
high
background
level
human
dna
make
uniqu
suit
molecular
test
bacteri
candida
dna
blood
sampl
clinic
blood
sampl
associ
clinic
chart
microbiolog
data
collect
irb
protocol
evalu
univers
diagnost
assay
rapid
accur
pathogen
identif
acut
care
set
approv
john
hopkin
medic
institut
intern
review
board
irbx
verbal
consent
obtain
subject
design
surrog
either
person
telephon
verbal
consent
document
copi
consent
script
consent
physician
consent
designe
consent
record
store
secur
locat
procedur
approv
jhmi
irb
base
minim
risk
harm
healthi
subject
blood
use
matrix
provid
biom
suppli
llc
carlsbad
california
collect
fda
licens
